SLXN
SLXN
NASDAQ · Biotechnology

Silexion Therapeutics Corp

$0.50
-0.05 (-9.31%)
As of May 16, 2:34 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +7,165.4% upside
Low Target $26.81
Average Target $36.24
High Target $52.45
Current Price $0.50
Current
$0.50
Target
$36.24
$26.81 $36.24 avg $52.45
Scenario Analysis
Bear Case
$26.81
5,274.9%
Low target
Base Case
$36.24
+7,165.4%
Avg target
Bull Case
$52.45
+10,415.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$22.36
-97.8% from high
52-Week Low
$0.46
+8.3% from low
Target vs 52W High
$36.24
+62.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%